ISSX 2025 International Meeting Conference ISSX 2025 International Meeting –CertaraSeptember 12, 2024
Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator Publication Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator The article "Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system…CertaraAugust 26, 2024
Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH) Publication Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH) The article “Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL)…CertaraAugust 26, 2024
How does a clinical development plan help drug programs? Blog How does a clinical development plan help drug programs? How important is a clinical development plan? Your biotechnology start-up’s candidate asset has an intriguing…CertaraJuly 26, 2024
A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator Publication A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator This collaborative effort by Certara and the Centre for Applied Pharmacokinetic Research (CAPKR) at The…CertaraJuly 24, 2024
A literature review of drug transport mechanisms during lactation Publication A literature review of drug transport mechanisms during lactation The literature review titled "A literature review of drug transport mechanisms during lactation," authored by…CertaraJuly 7, 2024
Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates Blog Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies…CertaraMay 10, 2024
Everything You Need to Know About SDTM Blog Everything You Need to Know About SDTM Find out all you need to know about CDISC SDTM, from the SDTM implementation guide…CertaraMarch 12, 2024
Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator Publication Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…CertaraFebruary 23, 2024
Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome Publication Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…CertaraJune 28, 2023